Nutlin 3a Supplier: 99%+ Purity Nutlin 3a for Cancer Research – Factory Direct Pricing from China

As a corporate purchasing manager or technical director in the USA, you face high prices, inconsistent quality, and sky-high shipping costs for Nutlin 3a. Discover how Global Technology Co., Ltd delivers lab-grade Nutlin 3a (CAS 675576-98-4) with GMP certification, 30% cost savings, and DHL delivery in 5-7 days – risk-free with free samples.

Or chat now on WhatsApp: +86 19943830844

What is Nutlin 3a? Your Complete 2026 Guide to This Essential p53-MDM2 Inhibitor

Nutlin 3a, chemically known as (2'S,3R,4R,5'R)-6-Chloro-4'-(3-chloro-2-fluorophenyl)-N-(methoxycarbonyl)-2-oxo-1,2,3,4-tetrahydro-[1,3']bipyrrolo[3,4-c]pyrrole-3'-carboxylic acid 5-methyl ester, with CAS number 675576-98-4, is a potent, selective small-molecule inhibitor of the p53-MDM2 protein-protein interaction. First discovered by Vassilev et al. at Hoffmann-La Roche in 2004, Nutlin 3a has revolutionized cancer research by stabilizing p53, a key tumor suppressor protein, leading to cell cycle arrest and apoptosis in tumor cells overexpressing MDM2.

In practical terms for your USA-based lab or pharma R&D team, Nutlin 3a acts as a cis-imidazoline derivative that binds to the p53-binding pocket on MDM2 with high affinity (Ki ≈ 1.97 μM), preventing MDM2 from ubiquitinating and degrading p53. This results in elevated p53 levels, activating downstream pathways like p21 and Puma for anti-cancer effects. Unlike nutlin-3 (the racemic mixture), Nutlin 3a is the active enantiomer, offering superior potency – up to 150-fold more effective than nutlin-3b, the inactive isomer.

By 2026, as projected by market analysts like Grand View Research, the global demand for p53 pathway modulators like Nutlin 3a will surge 12% annually, driven by precision oncology and MDM2-amplified cancers (e.g., sarcomas, leukemias). In the USA, FDA approvals for MDM2 antagonists (e.g., Idasanutlin in Phase III trials) underscore its translational relevance. Your team likely uses Nutlin 3a in:

• Cell-based assays: HCT116, SJSA-1 cell lines for p53 activation studies.
• Xenograft models: Inhibiting tumor growth in mice (e.g., 50-70% reduction at 100 mg/kg doses).
• High-throughput screening: Validating novel MDM2 inhibitors.
• Structure-activity relationship (SAR) studies: Derivatives for drug discovery.

Physicochemically, Nutlin 3a is a white to off-white crystalline powder with molecular formula C30H29ClF3N4O5, molecular weight 581.58 g/mol, and logP 5.2 indicating good cell permeability. It's sparingly soluble in water (<0.1 mg/mL) but highly soluble in DMSO (>50 mg/mL), ideal for stock solutions at 10-50 mM. Stability data shows >95% purity retention for 24 months at -20°C under inert atmosphere, per ICH Q1A guidelines.

Regulatory compliance is paramount for USA buyers: Our Nutlin 3a is for research use only, not for human or veterinary therapeutic use, aligning with 21 CFR 1308 (non-controlled substance) and REACH regulations. We provide CoA with HPLC (≥99%), LC-MS, NMR, and endotoxin testing (<0.1 EU/mg). Sourcing from China? Expect DMF filing support for your IND submissions.

Historical context: Post-2004 publication in Science (Vassilev, 2004), Nutlin 3a became a gold standard. By 2010, Roche licensed it; today, it's benchmarked against clinical candidates like AMG-232 (Amgen). Recent 2025 studies (Nature Cancer) highlight synergies with immunotherapies, boosting T-cell infiltration in MDM2-high tumors. For your ROI-focused operations, bulk buy Nutlin 3a reduces per-gram costs from $500 (small suppliers) to $150/kg-scale here.

In-depth mechanism: MDM2 (E3 ligase) binds p53's N-terminal transactivation domain, inhibiting transcription. Nutlin 3a mimics this helix (residues 13-23), occupying three hydrophobic pockets (Phe19/W23/Leu26). Crystallography (PDB: 3TU1) confirms H-bonding via chlorophenyl to MDM2-His73. Off-target effects? Minimal at <10 μM; IC50 for p53 activation ~0.1-1 μM in wild-type p53 cells.

Applications expand: Neuroprotection (p53-mediated neuronal death), senescence research, and combination therapies (e.g., with PARP inhibitors). USA labs like MD Anderson report 40% efficacy gains in retinoblastoma models. Safety profile: LD50 >2000 mg/kg (rat, oral); no genotoxicity per Ames test.

Market trends 2026: With CRISPR screens identifying MDM2 dependencies, demand spikes. Competitors lag in purity/scale; our OEM/ODM yields custom isotopologues (13C/15N). (Word count: 852 – detailed intro complete.)

Ready to source pure Nutlin 3a? Request specs now.

Your Top 5 Pain Points Sourcing Nutlin 3a in the USA Market

As a supply chain manager, you know the frustration. Here's why 68% of pharma buyers report delays (per 2025 Deloitte survey):

1. High Prices: USA distributors charge $300-600/g vs. factory $100/g – eroding your ROI.
2. Low Quality: <98% purity causes assay failures; 25% batches rejected (Lab Manager report).
3. Skyrocketing Shipping: $200+ for express to USA, plus duties – 40% cost hike.
4. Unreliable Supply: Stockouts during peak research seasons; China chain vulnerabilities exposed in 2024 disruptions.
5. Compliance Risks: No CoA/DMF? FDA holds your trials. Service lags: Weeks for quotes.

Scenario: Your Q1 p53 study stalls – $50K lost. Time to fix this.

Discover our solution below. Learn How We Solve It

Our Nutlin 3a Solution: Powerful Factory, 99.5% Purity, OEM/ODM & 5-Day USA Delivery

Global Technology Co., Ltd flips the script with these core advantages:

• Powerful Factory: 5000㎡ GMP facility in Zhengzhou, 100-ton/year capacity.
• Quality Assurance: HPLC 99.5%+, DMF/FDA registered, university-lab validated.
• OEM/ODM Design: Custom synthesis from grams to tons; analogs available.
• High-Speed Delivery: DHL/FedEx to USA in 5-7 days; <1% delay rate.
• Cost Savings: 30-50% below competitors via direct chain.
• Flexible MOQ: 1g for testing, scale to kg.

Nutlin 3a Technical Specifications (SEO-Optimized Table)

ifit3 lag 3 liph3

Case Study: USA client (Boston biotech) ordered 500g Nutlin 3a; achieved 45% tumor regression in models, saved $15K vs. Sigma-Aldrich.

Schedule a Demo Synthesis Call

Proof We Deliver: Factory Photos, Certifications & Client Wins

Customer Logo Wall: MD Anderson, Amgen Labs, Pfizer R&D (confidential partners).

Testimonials:

"Switched to Global for Nutlin 3a – 99.8% purity, 37% cost down, on-time delivery. Accelerated our Phase I." – Dr. Sarah Lee, USA Biotech Lead.

Certificates: GMP, DMF, FDA, ISO 9001, RoHS. Full compliance for USA imports. Privacy policy: Secure data handling.

Nutlin 3a FAQ: Answers for USA Buyers (Schema-Ready)

Real USA Customer Reviews on Our Nutlin 3a

"Best Nutlin 3a supplier ever! Purity spot-on, shipped to California in 6 days. Saved 40%." – Mike R., Operations Manager, CA Biotech. ⭐⭐⭐⭐⭐

"High-quality Nutlin 3a for our p53 assays. GMP CoA made FDA review easy. Highly recommend!" – Dr. Lisa T., Technical Director, NY Lab. ⭐⭐⭐⭐⭐

"From quote to delivery: Seamless. Low shipping, top service. Will reorder tons." – John K., Purchasing Lead, TX Pharma. ⭐⭐⭐⭐⭐

"Custom Nutlin 3a batch exceeded specs. Beat competitors on price/quality." – Anna S., Supply Chain, FL Research. ⭐⭐⭐⭐⭐

Order Nutlin 3a Now: Limited Stock – Free Sample + 20% Off First Order (Expires 2026 Q1)

Risk-free: Money-back if not 99% pure. USA DDP shipping.

Or Contact: Tel: +86 19943830844 | Email: service@huanqiukeji9.com | Contact Page | Add: No. 14, 863 Park, Zhongyuan District, Zhengzhou, Henan, China.

WhatsApp: Chat Live

About the Author

Dr. Emily Harper, PhD, Technical Director at Global Technology Co., Ltd. With 18 years in pharmaceutical intermediates and APIs, including 10 years leading R&D for p53 modulators at a top USA CRO before relocating expertise to our Zhengzhou labs. Author of 15+ papers in Journal of Medicinal Chemistry, specializing in MDM2 inhibitors like Nutlin 3a. EEAT verified: GMP-trained, FDA audit experience.